Evidence mapPaperPMID 41551943Full record

ArticleAging advances2025

Narrative review of mitochondrial dysfunction in aging-related salt-sensitive hypertension: outcomes, mechanisms, and therapeutic implications.

Sepiso K Masenga, Joreen P Povia, Bislom C Mweene, Ronald McMillian, Claude Albritton, Taneisha Gillyard, Jeremiah Afolabi, Edgar Garza Lopez, Benjamin Rodriguez, Amber Crabtree and 8 more

Abstract read
In one paragraph

Article in Aging advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sepiso K MasengaDepartment of Cardiovascular Science and Metabolic Diseases, Livingstone Center for Prevention and Translational Science, Livingstone, Zambia.
Joreen P PoviaDepartment of Cardiovascular Science and Metabolic Diseases, Livingstone Center for Prevention and Translational Science, Livingstone, Zambia.
Bislom C MweeneDepartment of Cardiovascular Science and Metabolic Diseases, Livingstone Center for Prevention and Translational Science, Livingstone, Zambia.
Ronald McMillianDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Claude AlbrittonDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Taneisha GillyardDepartment of Biomedical Sciences, Meharry Medical College, Nashville, TN, USA.
Jeremiah AfolabiDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Edgar Garza LopezDepartment of Biomedical Sciences, Meharry Medical College, Nashville, TN, USA.
Benjamin RodriguezDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Amber CrabtreeDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Salma AshShareefDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Margaret MungaiDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Han LeDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Andrea MarshallDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Prasanna KattiDepartment of Biology, Indian Institute of Science Education and Research (IISER), Tirupati, AP, India.
Kit NeikirkDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.
Annet KiraboDepartment of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Antentor HintonDepartment of Molecular Physiology & Biophysics, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-7730-952X

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$1.8M
PRIDE-Functional and Translational Genomics of Blood DisordersR25HL106365 · NHLBI · AUGUSTA UNIVERSITY · PI Betty Sue Pace · 2022 to 2023
$1.5M
Immune Mechanisms of Salt-Sensitive hypertensionR01HL144941 · VANDERBILT UNIVERSITY MEDICAL CENTER · 2025 to 2025
$572k
UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)D43TW009744 · UNIVERSITY OF ZAMBIA · 2025 to 2025
$112k
FIC NIH HHS D43 TW009744FIC NIH HHS R21 TW012635NHLBI NIH HHS R01 HL144941NHLBI NIH HHS R25 HL106365NIDDK NIH HHS P30 DK020593
6 · The paper itself

Abstract

Salt sensitivity of blood pressure is prevalent in the aging population, characterized by an exaggerated hypertensive response to dietary sodium intake. Emerging evidence implicates mitochondrial dysfunction as a central contributor to salt sensitivity of blood pressure with mechanistic involvement of oxidative stress, endoplasmic reticulum stress, disrupted mitochondrial-endoplasmic reticulum contacts, and impaired autophagy. This review explores the interplay between aging, mitochondrial dysfunction, and salt sensitivity of blood pressure. Morphological mitochondrial changes including mitochondrial fragmentation due to fission-fusion imbalances, cristae remodeling leading to bioenergetic deficits, and mitochondrial-endoplasmic reticulum contact disruptions affecting calcium homeostasis across aging are contextualized in salt sensitivity of blood pressure. Alongside these changes, age-associated impairments in mitophagy result in the accumulation of defective mitochondria, exacerbating oxidative stress and inflammation. Understanding these pathways offers potential therapeutic avenues to attenuate salt sensitivity of blood pressure in older adults.

Indexed as

agingcristae remodelingfissionfusionmitochondria-endoplasmic reticulum contactmitochondrial dynamicsmitochondrial dysfunctionmitochondrial-targeted therapiesoxidative stresssalt-sensitive hypertension

Identifiers

PMID41551943
PMCPMC12811007

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.